发明名称 OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION.
摘要 <p>Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof.</p>
申请公布号 MXPA05008319(A) 申请公布日期 2006.02.28
申请号 MX2005PA08319 申请日期 2004.02.10
申请人 SANTARIS PHARMA A/S 发明人 HANSEN, BO
分类号 A61K31/7088;A61P35/00;C12N;C12N15/113;(IPC1-7):A61K31/708;C12N00/00;C12N15/11 主分类号 A61K31/7088
代理机构 代理人
主权项
地址